Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Baxter
Harvard Business School
Boehringer Ingelheim
Moodys

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Azelastine Hydrochloride And Fluticasone Propionate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00651118 ↗ A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2008-03-01 The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
NCT00660517 ↗ A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2007-12-01 The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
NCT00740792 ↗ A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2008-08-01 The purpose of this study is to determine if two allergy medications (formulated azelastine and fluticasone product) are more effective than placebo or either medication alone (azelastine or fluticasone)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Azelastine Hydrochloride And Fluticasone Propionate

Condition Name

Condition Name for Azelastine Hydrochloride And Fluticasone Propionate
Intervention Trials
Seasonal Allergic Rhinitis 9
Allergic Rhinitis 5
Allergy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Azelastine Hydrochloride And Fluticasone Propionate
Intervention Trials
Rhinitis, Allergic 15
Rhinitis 15
Rhinitis, Allergic, Seasonal 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Azelastine Hydrochloride And Fluticasone Propionate

Trials by Country

Trials by Country for Azelastine Hydrochloride And Fluticasone Propionate
Location Trials
United States 65
Canada 3
Germany 2
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Azelastine Hydrochloride And Fluticasone Propionate
Location Trials
Texas 4
Pennsylvania 4
Illinois 4
Arizona 3
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Azelastine Hydrochloride And Fluticasone Propionate

Clinical Trial Phase

Clinical Trial Phase for Azelastine Hydrochloride And Fluticasone Propionate
Clinical Trial Phase Trials
Phase 4 6
Phase 3 5
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Azelastine Hydrochloride And Fluticasone Propionate
Clinical Trial Phase Trials
Completed 8
Unknown status 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Azelastine Hydrochloride And Fluticasone Propionate

Sponsor Name

Sponsor Name for Azelastine Hydrochloride And Fluticasone Propionate
Sponsor Trials
MEDA Pharma GmbH & Co. KG 4
Meda Pharmaceuticals 4
ClinResearch, GmbH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Azelastine Hydrochloride And Fluticasone Propionate
Sponsor Trials
Industry 13
Other 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
Moodys
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.